SLC5A2 and keratitis: In the subgroup analyses, the usage of SGLT2 inhibitors correlated to a grossly lower incidences of superficial keratopathy and infectious keratitis compared to the non-SGLT2 inhibitors users (all aHRs < 1), although several SGLT2 inhibitors subgroups showed a similar incidence of infectious keratitis as non-SGLT2 inhibitors population (Table 5).